Robert J. Fallis

909 total citations
16 papers, 524 citations indexed

About

Robert J. Fallis is a scholar working on Immunology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Robert J. Fallis has authored 16 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Pathology and Forensic Medicine and 5 papers in Oncology. Recurrent topics in Robert J. Fallis's work include Multiple Sclerosis Research Studies (6 papers), T-cell and B-cell Immunology (5 papers) and Polyomavirus and related diseases (5 papers). Robert J. Fallis is often cited by papers focused on Multiple Sclerosis Research Studies (6 papers), T-cell and B-cell Immunology (5 papers) and Polyomavirus and related diseases (5 papers). Robert J. Fallis collaborates with scholars based in United States and Slovakia. Robert J. Fallis's co-authors include Howard L. Weiner, D. E. McFarlin, David A. Hafler, Richard M. McCarron, David Johnson, Mark A. Fisher, Roscoe O. Brady, Marjorie B. Lees, Richard H. Quarles and Stephen L. Hauser and has published in prestigious journals such as The Journal of Immunology, Neurology and Annals of the New York Academy of Sciences.

In The Last Decade

Robert J. Fallis

16 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J. Fallis United States 11 335 189 103 76 75 16 524
G. Grimsley Australia 8 119 0.4× 374 2.0× 58 0.6× 87 1.1× 242 3.2× 14 592
Michael P. Crawford United States 9 489 1.5× 350 1.9× 14 0.1× 71 0.9× 51 0.7× 20 736
Merle Haust Germany 11 254 0.8× 172 0.9× 114 1.1× 22 0.3× 45 0.6× 14 514
Osheik Seidi United Kingdom 10 111 0.3× 132 0.7× 17 0.2× 127 1.7× 66 0.9× 17 360
Alexandra Garcia France 12 315 0.9× 178 0.9× 18 0.2× 117 1.5× 145 1.9× 26 622
Takeshi Kezuka Japan 14 111 0.3× 153 0.8× 24 0.2× 65 0.9× 124 1.7× 20 495
Benjamin Schrijver Netherlands 13 233 0.7× 92 0.5× 15 0.1× 106 1.4× 32 0.4× 29 545
Eva Simmons-OʼBrien United States 6 58 0.2× 54 0.3× 46 0.4× 50 0.7× 86 1.1× 7 429
Maria Grazia Piccinno Italy 10 161 0.5× 174 0.9× 7 0.1× 58 0.8× 96 1.3× 15 471
Valentina Bardina Italy 9 157 0.5× 163 0.9× 15 0.1× 67 0.9× 41 0.5× 15 416

Countries citing papers authored by Robert J. Fallis

Since Specialization
Citations

This map shows the geographic impact of Robert J. Fallis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Fallis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Fallis more than expected).

Fields of papers citing papers by Robert J. Fallis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Fallis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Fallis. The network helps show where Robert J. Fallis may publish in the future.

Co-authorship network of co-authors of Robert J. Fallis

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Fallis. A scholar is included among the top collaborators of Robert J. Fallis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Fallis. Robert J. Fallis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wilken, Jeffrey, Robert L Kane, Mark Gudesblatt, et al.. (2013). Changes in Fatigue and Cognition in Patients with Relapsing Forms of Multiple Sclerosis Treated with Natalizumab. International Journal of MS Care. 15(3). 120–128. 33 indexed citations
2.
McCarron, Richard M., Robert J. Fallis, & D. E. McFarlin. (1990). Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis. Journal of Neuroimmunology. 29(1-3). 73–79. 101 indexed citations
3.
Fallis, Robert J., Cedric S. Raine, & Dale E. McFarlin. (1989). Chronic relapsing experimental allergic encephalomyelitis in SJL mice following the adoptive transfer of an epitope-specific T cell line. Journal of Neuroimmunology. 22(2). 93–105. 36 indexed citations
4.
Fallis, Robert J. & D. E. McFarlin. (1989). Chronic relapsing experimental allergic encephalomyelitis. Cytotoxicity effected by a class II restricted T cell line specific for an encephalitogenic epitope.. The Journal of Immunology. 143(7). 2160–2165. 19 indexed citations
5.
Dawson, David M., et al.. (1988). Cumulative Experience with High‐Dose Intravenous Cyclophosphamide and ACTH Therapy in Chronic Progressive Multiple Sclerosis. Annals of the New York Academy of Sciences. 540(1). 535–536. 3 indexed citations
6.
McCarron, Richard M., Robert J. Fallis, & D. E. McFarlin. (1988). Alterations in the Pattern of MHC Restriction of T Cells in Relapsing Murine Experimental Allergic Encephalomyelitis. Annals of the New York Academy of Sciences. 540(1). 349–351. 5 indexed citations
7.
Fallis, Robert J., M. Linda Powers, & Howard L. Weiner. (1987). Serial analysis of peripheral blood T‐cell phenotypes and myelin basic protein reactivity in experimental allergic encephalomyelitis. Neurology. 37(4). 719–719. 5 indexed citations
8.
Hauser, Stephen L., et al.. (1987). Immunoregulatory abnormalities induced by experimental reovirus infection: Functional alterations in T-cell subpopulations. Clinical Immunology and Immunopathology. 45(3). 481–490. 1 indexed citations
9.
Fallis, Robert J., M. Linda Powers, Man‐Sun Sy, & Howard L. Weiner. (1987). Adoptive transfer of murine chronic-relapsing autoimmune encephalomyelitis. Journal of Neuroimmunology. 14(2). 205–219. 43 indexed citations
10.
Hafler, David A., Robert J. Fallis, David M. Dawson, et al.. (1986). Immunologic responses of progressive multiple sclerosis patients treated with an anti‐T‐cell monoclonal antibody, anti‐T12. Neurology. 36(6). 777–777. 51 indexed citations
11.
Johnson, David, David A. Hafler, Robert J. Fallis, et al.. (1986). Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in multiple sclerosis. Journal of Neuroimmunology. 13(1). 99–108. 112 indexed citations
12.
Fallis, Robert J. & Mark A. Fisher. (1985). Cerebral vasculitis and hemorrhage associated with phenylpropanolamine. Neurology. 35(3). 405–405. 43 indexed citations
13.
Weiner, Howard L., Stephen L. Hauser, David A. Hafler, et al.. (1984). The Use of Cyclophosphamide in the Treatment of Multiple Sclerosisa. Annals of the New York Academy of Sciences. 436(1). 373–381. 15 indexed citations
14.
Weiner, Howard L., David A. Hafler, Robert J. Fallis, et al.. (1984). T Cell Subsets in Patients with Multiple Sclerosis: An Overviewa. Annals of the New York Academy of Sciences. 436(1). 281–290. 13 indexed citations
15.
Weiner, Howard L., David A. Hafler, Robert J. Fallis, et al.. (1984). Altered blood T-cell subsets in patients with multiple sclerosis. Journal of Neuroimmunology. 6(2). 115–121. 43 indexed citations
16.
Fallis, Robert J., et al.. (1982). Massive Phencyclidine Intoxication. Archives of Neurology. 39(5). 316–316. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026